Zefcort 6mg Tablet contains Deflazacort, a corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the management of various inflammatory and autoimmune conditions, including rheumatoid arthritis, systemic lupus erythematosus, allergic reactions, and certain dermatological disorders. Deflazacort exerts its therapeutic effects by modulating the immune response and reducing inflammation through inhibition of multiple inflammatory cytokines and mediators. Zefcort is also utilized in the treatment of Duchenne muscular dystrophy to improve muscle strength and function. The 6mg dosage provides an effective balance between efficacy and safety, minimizing potential corticosteroid-related adverse effects such as hyperglycemia, osteoporosis, and adrenal suppression. Administration should be tailored to the individual patient’s condition, severity, and response, with gradual tapering recommended to avoid withdrawal symptoms. Common side effects may include gastrointestinal discomfort, mood alterations, increased susceptibility to infections, and fluid retention. Caution is advised in patients with pre-existing infections, diabetes, hypertension, or peptic ulcer disease. Zefcort 6mg Tablet should be used under strict medical supervision, with regular monitoring to optimize therapeutic outcomes and minimize risks associated with long-term corticosteroid therapy.